Lunaphore, Abcam Comarketing Antibodies for Use in Spatial Proteomics
Under the agreement, the companies will comarket Abcam antibodies validated for use on Lunaphore's COMET spatial proteomics platform.
Abcam to License Phage Library from Twist Bioscience for Antibody Discovery, Diagnostics
The deal "lays the foundations for a long-term collaboration with Abcam to drive new commercial opportunities," Twist CEO Emily Leproust said.
Alamar Biosciences, Abcam Partner for Proteomics Research
The companies aim to bring together Alamar's immunoassay-based NULISA proteomics platform and Abcam's extensive antibody portfolio.
Abcam to Acquire Life Science Research Tool Firm BioVision for $340M
BioVision, which has been supplying products to Abcam since 2003, generated $33.8 million in revenues last year.
Cancer Research UK, Abcam Partner to Develop Custom Antibodies for Cancer Research
Abcam will develop custom protein-based reagents for
Mar 4, 2020
Abcam Acquires Marker Gene Technologies
May 9, 2018
Abcam Drops Takeover Bid for Horizon Discovery
May 26, 2017
Apr 21, 2017
Nov 11, 2015
Abcam Acquiring AxioMx for $45M
Sep 9, 2015
Horizon Discovery, Abcam Ink Licensing Deal
Jan 21, 2015
Abcam to Acquire Firefly BioWorks for $28M
Sep 9, 2014
Mar 30, 2012
May 24, 2011